FDA
Fosaprepitant Dimeglumine
The FDA lists this product in 21 strengths and forms.
Composition
- Active ingredients
- FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL · PowderANDA212957-002 · Discontinued
- FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL · PowderANDA214616-001 · Prescription
- FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL · PowderANDA210689-001 · Discontinued
- FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL · PowderANDA211860-001 · Prescription
- FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL · PowderThis page
- FOSAPREPITANT DIMEGLUMINE EQ 115MG BASE/VIAL · PowderANDA204015-001 · Discontinued
- FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL · PowderANDA204015-002 · Prescription
- FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL · PowderANDA211160-001 · Prescription
- FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL · PowderNDA210064-001 · Prescription
- FOSAPREPITANT DIMEGLUMINE UNKNOWN · UnknownANDA204845-001 · Tentative approval
At a glance
- Brand name
- Fosaprepitant Dimeglumine
- Route
- Intravenous
- Dosage form
- Powder
- Applicant
- Praxgen
- Status
- Discontinued
- FDA approval
- 4 Oct 2021
- Application
- ANDA213199-001
- RxCUI
- 754763